Chief, Lab of Inflammation and Cardiometabolic Diseases
National Institutes of Health, National Heart Lung and Blood Institute
Bethesda, Maryland, United States
Dr. Mehta is a nuclear, general and preventive cardiologist at the NHBLI Intramural Research Program. He is also Professor of Medicine at the George Washington University where he attends on the coronary care unit. His research program focuses on the role of innate immunity and inflammation in subclinical atherosclerosis. He utilizes psoriasis as a human model to study cardiometabolic diseases. His trans-disciplinary approach involves genetic epidemiology, cardiovascular radiology and translational medicine to perform observational and experimental studies in humans. Dr. Mehta’s group has shown that severity of inflammation in skin relates to lipoprotein dysfunction, insulin resistance, lipid-rich coronary plaque by CCTA and vascular inflammation by FDG PET/CT. His group recently demonstrated that lipid-rich coronary plaque decreased following successful skin disease treatment with biologic therapy. Dr. Mehta has expertise in leading large collaborative teams. His background in lipidology, Preventive Cardiology,Nuclear Cardiology and Epidemiology facilitate multi-disciplinary science.